Ginkgo Bioworks Holdings (DNA) Goodwill & Intangibles (2019 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Goodwill & Intangibles of $48.9 million for Q1 2026, down 8.64% on a QoQ basis from $53.5 million in Q4 2025, and down 28.94% year-over-year from $68.8 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $48.9 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 28.94% year-over-year to $48.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.9 million (down 28.94% YoY) and the FY2025 annual result came in at $53.5 million, down 26.24% from the prior year.
- Goodwill & Intangibles was $48.9 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $53.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $171.3 million in Q4 2022 and bottomed at $41.9 million in Q1 2022.
- A 5-year average of $88.1 million and a median of $72.5 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles jumped 298.68% — and 2024, when it slumped 49.71%.
- Ginkgo Bioworks Holdings' Goodwill & Intangibles stood at $171.3 million in 2022, then fell by 22.93% to $132.0 million in 2023, then slumped by 45.06% to $72.5 million in 2024, then declined by 26.24% to $53.5 million in 2025, then dropped by 8.64% to $48.9 million in 2026.
- Business Quant data shows DNA's Goodwill & Intangibles at $48.9 million in Q1 2026, $53.5 million in Q4 2025, and $61.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.86 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 61.52 Mn |
| Jun 30, 2025 | 66.15 Mn |
| Mar 31, 2025 | 68.76 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 125.32 Mn |
| Dec 31, 2023 | 131.98 Mn |
| Sep 30, 2023 | 158.23 Mn |
| Jun 30, 2023 | 107.23 Mn |
| Mar 31, 2023 | 110.94 Mn |
| Dec 31, 2022 | 171.25 Mn |
| Sep 30, 2022 | 58.94 Mn |
| Jun 30, 2022 | 50.18 Mn |
| Mar 31, 2022 | 41.87 Mn |
| Dec 31, 2021 | 42.95 Mn |
| Sep 30, 2021 | 37.75 Mn |
| Dec 31, 2020 | 5.15 Mn |